Gentamicin C1a pentaacetate

CAS: 26098-04-4

Ref. 3D-AG16458

Informação sobre produto

• Nome: Gentamicin C1a pentaacetate
• Sinónimos: O-3-Deoxy-4-C-methyl-3-(methylamino)-b-L-arabinopyranosyl-(1-6)-O-[2,6-diamino-2,3,4,6-tetradeoxy-a-D-erythro-hexopyranosyl-(1-4)]-2 -deoxy-D-streptamine pentaacetate saltGentamicin D acetateGentamycin C1a acetate, <span class="text-smallcaps">D</smallcap>-Streptamine, O-3-deoxy-4-C-methyl-3-(methylamino)-β-<smallcap>L</smallcap>-arabinopyranosyl-(1→6)-O-[2,6-diamino-2,3,4,6-tetradeoxy-α-<smallcap>D</span>-erythro-hexopyranosyl-(1→4)]-2-deoxy-, Geneticin C_1a, Gentamicin C1a, Gentamicin C_1a, Gentamicin C₃, Gentamycin C_1a, O-3-Deoxy-4-C-methyl-3-(methylamino)-β-<span class="text-smallcaps">L</smallcap>-arabinopyranosyl-(1→6)-O-[2,6-diamino-2,3,4,6-tetradeoxy-α-<smallcap>D</smallcap>-erythro-hexopyranosyl-(1→4)]-2-deoxy-<smallcap>D</span>-streptamine
• CAS: 26098-04-4

Descrição

Gentamicin C1a pentaacetate is a prodrug that is converted to gentamicin, its active form, by the enzyme diacetyl reductase. Gentamicin C1a pentaacetate has minimal toxicity and can be used for the treatment of infections caused by gram-positive species. This drug has been shown to be effective against bowel disease and infectious diseases. Gentamicin C1a pentaacetate is enzymatically inactivated by the wild-type strain of Escherichia coli and other gram-negative bacteria. The matrix effect may affect the pharmacokinetics of this drug, which can be studied using an analytical method.

• Marca: Biosynth

Propriedades químicas

• Peso molecular: 749.8 g/mol
• Fórmula: C₂₉H₅₉N₅O₁₇
• Pureza: Min. 95%
• Cor/forma: Off-White Powder